Islamabad: The two-day Pak-China Pharmaceutical and Healthcare B2B Investment Conference will commence in Islamabad from tomorrow. The event aims to foster collaboration and investment in the pharmaceutical, healthcare, and biotechnology sectors between Pakistan and China. According to Radio Pakistan, the conference is a collaborative effort organized by the Special Investment Facilitation Council (SIFC), the Ministry of National Health Services, and the Drug Regulatory Authority of Pakistan. The primary objective is to encourage investment and industrial cooperation, enhancing the strategic partnership between the two nations in the healthcare domain. The event is expected to draw nearly five hundred local and international delegates and businessmen. These participants will explore various investment opportunities within the healthcare sector, with a particular focus on strengthening ties between companies from Pakistan and China. The conference will feature business-to-business (B2B) meetings, networking opportunities, and dedicated investment sessions, providing a platform for meaningful engagement and collaboration.